Navigation Links
Peregrine Pharmaceuticals Awarded DTRA Contract Worth up to $44.4 Million to Develop Bavituximab for Viral Hemorrhagic Fevers
Date:7/1/2008

- Five-Year Defense Threat Reduction Agency Contract Will Support

Development of Bavituximab and Fully Human Equivalent as Potential

Broad-Spectrum Anti-Viral Agents -

TUSTIN, Calif., July 1 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical stage biopharmaceutical company developing monoclonal antibodies for the treatment of cancer and hepatitis C virus (HCV) infection, today announced it has entered into a five-year contract worth up to $44.4 million to test and develop bavituximab and an equivalent fully human antibody as potential broad-spectrum treatments for viral hemorrhagic fever infections. The initial contract was awarded through the Transformational Medical Technologies Initiative (TMTI) of the U.S. Department of Defense's Defense Threat Reduction Agency (DTRA).

Bavituximab is Peregrine's lead anti-phosphatidylserine (anti-PS) monoclonal antibody and is currently in clinical trials for the treatment of HCV infections and cancer. In preclinical animal models, bavituximab has demonstrated encouraging anti-viral activity as a potential treatment for viral hemorrhagic fevers. Peregrine's fully human anti-PS antibody, which will also be assessed under this contract, is currently in preclinical development.

Under the terms of the contact, DTRA funds are available to cover testing and development efforts totaling up to $22.3 million over a 24-month base period, with $5 million appropriated immediately for the current federal fiscal year ending September 30, 2008. The remainder of the $22.3 million in funding is expected to be appropriated over the remainder of the two-year base period ending June 29, 2010. The contract can be extended beyond the base
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Peregrine Pharmaceuticals Presents Promising Phase I Data at ASCO and Provides Clinical Update on Its Phase II Bavituximab Breast Cancer Study
2. Peregrine Pharmaceuticals Reports Studies Published in Science Highlight Key Role of Phosphatidylserine (PS) in Viral Infections
3. Peregrine Pharmaceuticals Announces Four Upcoming Presentations at the American Association for Cancer Research 2008 Annual Meeting
4. Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008
5. Peregrine Pharmaceuticals to Announce Third Quarter FY 2008 Financial Results
6. Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity
7. Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer
8. Peregrine Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
9. Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008
10. Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program
11. Peregrine Pharmaceuticals to Announce Second Quarter FY 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 More than 5 ... about 1 in 3 seniors will die with Alzheimer’s ... These jaw-dropping figures have shocked many Americans into looking ... help prevent these tragic age-related cognitive disorders. Jonathan Weisman, ...
(Date:1/15/2014)... 15, 2014 2013 was a banner ... State Technologies®. They saw continued independent research led by ... were awarded a $1 million grant from the Susanne ... and Behavior” a peer reviewed journal, Amy Grant highlighted ...
(Date:1/14/2014)... Date: Friday, April 11, 2014 , Time: 6 p.m. – ... Warrington, Pa. , Details: The Hepatitis B Foundation, ... cure for hepatitis B and improving the quality of life ... on Friday, April 11 at Warrington Country Club in Warrington, ...
(Date:1/14/2014)... , Jan. 14, 2014 As pet owners drew up their ... of them wrote: "Take better care of my furry companion." Nowadays ... clothes and top-brand carrying cases to take the little canine or ... also feel compelled to buy some pricey toys at the pet ...
Breaking Biology Technology:Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2
... electrical engineer at the University at Buffalo, who previously ... that could boost optical data storage and communications -- ... the rainbow. , In a paper published March 29 ... Qiaoqiang Gan (pronounced "Chow-Chung" and "Gone"), PhD, an assistant ...
... Biotech Medical, Inc. is set to launch a ... Enzymes". The products will be available for purchase online ... Stain & Odor Eraser, Spa & Whirlpool Cleaner, Mold ... & Degreaser, Glass & Stainless Steel Cleaner and a ...
... 12, 2011 Bio Careers, the leading online career ... the launch of Individual Memberships. Previously, Bio Careers was ... of its member institutions. Now, membership is open to ... institutions, as ranked by the Academic Ranking of World ...
Cached Biology Technology:Rainbow-trapping scientist now strives to slow light waves even further 2Biotech Medical, Inc. Introduces a Full Line of Enzyme Cleaners 2Online Career Service for Postgraduate Life Scientists Expands Membership to Individuals 2
(Date:7/10/2014)... Ore. Nuclear engineers at Oregon State University have ... device that should help people all over the world ... intensity, and whether or not it poses a health ... to public demand following the nuclear incident in Fukushima, ... what level of radiation they were being exposed to ...
(Date:7/10/2014)... and teens living with a cardiac pacemaker, a low ... of life, reports a study in the July ... the official journal of the Society for Developmental ... by Lippincott Williams & Wilkins , a part ... function as a protective factor against lower health-related quality ...
(Date:7/10/2014)... funding cutting-edge, innovative research on Alzheimer,s disease and ... today announced the recipients of new research grant ... states, the District of Columbia, and five foreign ... these latest grants, BrightFocus has now provided more ... , The research projects funded this year reflect ...
Breaking Biology News(10 mins):Sophisticated radiation detector designed for broad public use 2Sophisticated radiation detector designed for broad public use 3For children with pacemakers, 'self-competence' affects quality of life 2BrightFocus Foundation announces 55 new grantees in Alzheimer's and vision research 2BrightFocus Foundation announces 55 new grantees in Alzheimer's and vision research 3
... a tool that can precisely deliver tiny doses of ... the Nanofountain Probe, functions in two different ways: in ... wherein drug-coated nanodiamonds serve as the ink, allowing researchers ... mode functions as a single-cell syringe, permitting direct injection ...
... in the 21st century may be found by thinking ... and cyanobacteria, to fungi and microalgae, are biological factories ... environmentally friendly biofuels that can serve as alternatives to ... Meeting of the American Society for Microbiology. "We ...
... 2009) Pregnant women who are indigenous to the Andes Mountains ... altitude than do women of European descent. The study helps ... weigh more than European babies born at altitude. The ... and Comparative Physiology found that at high altitude: ...
Cached Biology News:New tool for next-generation cancer treatments using nanodiamonds 2New tool for next-generation cancer treatments using nanodiamonds 3Scientists work to plug microorganisms into the energy grid 2Scientists work to plug microorganisms into the energy grid 3Babies born to native high-altitude mothers have decreased risk of low birth weight 2Babies born to native high-altitude mothers have decreased risk of low birth weight 3
...
Mitochondria/Cytosol Fractionation Kit Research Focus: other Storage Temperature: 4C Shipping Temperature: 4C...
Mouse monoclonal [5H9] to RAD52 ( Abpromise for all tested applications). entrezGeneID: 5893 SwissProtID: P43351...
Polyclonal Antibody to Golgin-67...
Biology Products: